ホームページへ

Bone Marrow Transplant for Pediatric Ewing Sarcoma

イスラエル ラマト・ガン
Map
シェバ医療センター
クリニックを見る
5
医師 5.0
スタッフ 5.0
施設 5.0
言語サポート 5.0
サポート 5.0
強く推奨
98%のクライアントがこのクリニックを推奨
12 患者
昨年このクリニックでの治療を選択されました

このパッケージに含まれるもの

医療処置
  • 生検
  • 腫瘍専門医の診察
  • 全血球計算検査
  • Ewing肉腫の複合診断
  • 放射線科医による診察
  • 血液検査
  • 検査
  • PET-CT検査
  • シンチグラフィ検査
  • ユーイング肉腫の複雑治療
  • HIV抗体検査
  • B型肝炎コア抗体検査
  • 抗HCV抗体検査
  • 血液検査
  • 生化学血液検査
  • 生検
  • 胸部X線
  • 全血球計算(CBC)
  • 循環器科医への相談
  • 小児血液専門医との相談
  • 小児科医との相談
  • 骨塩定量検査(CBM)
  • 腫瘍マーカーおよび蛋白分画を含む全血球算定
  • 心電図(ECG)
  • 心エコー図検査
  • 頭部MRI
  • PET/CT
  • 腫瘍血液専門医との診察
  • 24時間看護サービス
  • 栄養士による1日3食
期間
  • 30 日 病院で
宿泊

入院

交通
  • 空港-クリニック-空港間の送迎

追加情報

Bone Marrow Transplant for Pediatric Ewing Sarcoma

Sheba Medical Center – Advanced, Personalized Transplant Care for Children

At Sheba Medical Center, we understand how overwhelming it can be for families to face a diagnosis of Ewing Sarcoma. This rare and aggressive childhood cancer requires highly specialized care, precision treatment, and a deeply supportive environment for both the child and their family.

For children with high-risk, recurrent, or treatment-resistant Ewing Sarcoma, bone marrow transplantation (BMT) may be considered as part of an advanced treatment strategy, offering a powerful approach aimed at improving long-term outcomes.

Our pediatric transplant program combines world-class expertise, innovative therapies, and compassionate, family-centered care at every stage of the journey.

When is a Bone Marrow Transplant Needed?

Bone marrow transplantation is not part of standard treatment for all children with Ewing Sarcoma, but may be recommended in specific situations, including:

High-risk disease, particularly with spread beyond the primary tumor
Relapsed Ewing Sarcoma, when the disease returns after initial treatment
Refractory disease, when standard therapies are not sufficient

In these cases, BMT allows the use of high-dose chemotherapy to target cancer cells, followed by the infusion of healthy stem cells to restore the bone marrow and immune system.

Types of Transplant

Autologous Transplant (Child’s Own Cells)

This is the most commonly used transplant approach in Ewing Sarcoma when BMT is indicated.

Stem cells are collected from the child in advance
Intensive therapy is administered to eliminate cancer cells
The child’s own stem cells are reinfused to support recovery

This approach enables the safe delivery of higher-intensity treatment.

Allogeneic Transplant (Donor Cells)

In carefully selected cases, Sheba Medical Center also offers allogeneic (donor) transplantation as part of a comprehensive treatment strategy.

This option may be considered for:

Children who require an alternative stem cell source
Situations where an additional immune-based approach may be beneficial

Donor options at Sheba include:

Matched sibling donors
Matched unrelated donors through international registries
Haploidentical (half-matched) family donors

A key advantage of donor transplantation is the graft-versus-tumor effect, where the new immune system may help recognize and target remaining cancer cells.

Precision Matching and Advanced Technology

Sheba Medical Center utilizes an advanced on-site HLA laboratory to perform high-resolution genetic matching, ensuring the best possible compatibility between donor and child.

This precision supports safer transplantation and optimal outcomes.

Advanced Pediatric Sarcoma Care

Treatment for Ewing Sarcoma at Sheba is highly coordinated and personalized:

Integration of chemotherapy, surgery, and radiotherapy with transplant strategies
Access to innovative and targeted therapies when appropriate
Close collaboration between pediatric oncologists, orthopedic surgeons, and transplant specialists
Advanced supportive care throughout treatment
Specialized Pediatric Transplant Environment

Children undergoing transplantation are cared for in dedicated pediatric units designed to support healing and comfort:

Child-friendly, protected environments
Advanced infection prevention systems
Continuous monitoring by experienced pediatric teams

Every aspect of care is tailored to the needs of growing children.

Clinical Expertise

Sheba Medical Center is a leading center for pediatric oncology and transplantation, offering:

Experience in managing complex and high-risk Ewing Sarcoma cases
Expertise in high-dose therapy with stem cell support
Outcomes aligned with leading international centers
Long-term follow-up focused on recovery, growth, and quality of life
Care That Supports the Whole Family

We understand that treating a child means supporting the entire family.

At Sheba, families are guided by a multidisciplinary team including physicians, nurses, psychologists, and care coordinators ensuring clear communication, emotional support, and continuity of care throughout the journey.

Why Families Choose Sheba for Pediatric BMT

Leading pediatric transplant center
Expertise in rare and complex sarcomas
Access to a wide range of donor options
Advanced treatment technologies
Compassionate, child-centered care
Dedicated international patient services

A Message of Hope

At Sheba Medical Center, we combine advanced science with compassionate pediatric care. Even in complex conditions like Ewing Sarcoma, our goal is to provide every child with the strongest possible chance for recovery—while supporting families with confidence, care, and hope every step of the way.

24時間年中無休Bookimedサポート
  • 専任医療コーディネーター
  • 医療旅行手配 — 特別パートナー価格での航空券・ホテル予約
  • 医療旅行中の患者擁護

プログラム料金

$160,000

このパッケージに含まれないもの

航空運賃
ホテル
含まれない追加活動

医師

Hana Golan
Hematologist
24年の経験
委員会認定プロフェッショナル

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

続きを読む
医師プロフィールを見る

調子はいかがですか?

1 の 3
このプログラムの情報は完全で明確です
1
2
3
4
5
強く反対
強く賛成

クリニックについて

すべての写真を表示
シェバ医療センター

シェバ医療センターはイスラエルおよび世界有数の病院の一つです。 ニューズウィーク・インターナショナル誌は、Sheba Hospitalを2020年の世界トップ10病院にランク付けしました。同病院は1,990の専門分野をカバーしており、毎年世界中から1,500,000人を超える患者がシェバ病院を受診しています。

支払い・特典

当社サービスへのお支払いはありません

クリニックで直接またはその公式銀行口座にお支払いいただきます。

安全な予約

一部のクリニックでは保証金が必要な場合があります。

柔軟な分割払い

分割払いオプションでお支払いを分散してください。

紹介プログラム

Bookimedにお友達を紹介して報酬を獲得してください。

所在地
Derech Sheba 2, Ramat Gan, Israel

なぜ皆様に愛されるのか

こちらもお気に入りかもしれません

$160,000
パッケージあたり
5.0
2 レビュー